IFRX
InflaRx N.V.
NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY
$1.98
+18.56% today
Updated 2026-04-29
Market cap
$116.39M
P/E ratio
—
P/S ratio
3,968.21x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
InflaRx N.V. (IFRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
37,898.00%
ROE
-88.60%
ROA
-46.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-4.92M | — | — | — |
| 2016 | $0.00 | $-8.94M | — | — | — |
| 2017 | $231000.00 | $-24.24M | 71.13% | -8,417.75% | -10,492.64% |
| 2018 | $0.00 | $-29.82M | — | — | — |
| 2019 | $0.00 | $-59.61M | — | — | — |
| 2020 | $0.00 | $-38.74M | — | — | — |
| 2021 | $0.00 | $-53.93M | — | — | — |
| 2022 | $0.00 | $-30.99M | — | — | — |
| 2023 | $63089.00 | $-42.67M | -743.67% | -71,182.13% | -67,630.69% |
| 2024 | $165789.00 | $-46.06M | -1,900.76% | -31,973.69% | -27,784.96% |
| 2025 | $28173.00 | $-43.83M | -26,108.47% | -173,594.03% | -155,584.20% |